Wellcome Trust - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Wellcome Trust (Wellcome) is a charity that funds research organizations and research communities. It offers funding schemes to support individual researchers, teams and resources. The trust provides funds in areas of biomedical science, public engagement, humanities, innovations, social science, population health, and product development and applied research. It services include funding, grant management, education resources, and investment. The trust offers its education services for PhD students, post-docs and clinicians. It supports scientists, educators, innovators, and artists across the world. The trust works with partner organizations such as academia, business, governments, philanthropy, and civil society. Wellcome is headquartered in London, the UK.

Wellcome Trust - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Wellcome Trust, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Wellcome Trust, Medical Devices Deals, 2012 to YTD 2018 10
Wellcome Trust, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Wellcome Trust, Pharmaceuticals & Healthcare, Deal Details 14
Venture Financing 14
Corinnova Raises USD6.1 Million from Wellcome Trust 14
Azellon Raises USD2 Million in Venture Financing 15
Kymab Raises USD100.5 Million in Series C Financing 17
Nabriva Therapeutics Raises USD120 Million in Series B Financing 19
Kymab Raises USD40 Million in Series B Financing 21
Pcovery Raises USD4 Million in Venture Financing 22
Biocartis Raises US$40.5 Million In Series E Financing 23
Pcovery Raises USD5.7 Million in Seed Financing 25
Trino Therapeutics Raises US$12 Million In Series A Financing 26
Canbex Therapeutics Raises US$3 Million In Venture Financing 28
Partnerships 29
Sigma-Aldrich Enters into Agreement with Sanger Institute 29
AstraZeneca Enters into Research Agreement with Wellcome Trust Sanger Institute 30
Merck Serono Enters into Co-Development Agreement with Institute of Cancer Research and Wellcome Trust 31
Katholieke Universiteit Leuven And Wellcome Trust Enter Into Agreement With Janssen Pharma To Develop Dengue Antiviral Drugs 32
Licensing Agreements 34
Basilea Pharma Enters into Licensing Agreement for Novel PanRAF Kinase Inhibitors 34
Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute 35
Equity Offering 36
Microbiotica Spin Off from Wellcome Trust Sanger Institute 36
Debt Offering 37
Karuna Pharma Raises USD3.4 Million in Private Placement of Notes 37
Acquisition 38
Ergomed Acquires Haemostatix 38
GlaxoSmithKline Acquires Remaining Stake in GlycoVaxyn for USD190 Million 40
Wellcome Trust - Key Competitors 42
Wellcome Trust - Key Employees 43
Wellcome Trust - Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Recent Developments 45
Government and Public Interest 45
May 24, 2018: Bristol Professor awarded 1.5 million to look deeper into our cells quality control mechanism 45
May 01, 2018: $4.6M boost in search for new malaria drugs 46
Dec 11, 2017: Scientists discover new way to help nerve regeneration in spinal cord injury 48
Dec 08, 2017: 3.9m project to support elimination of the worlds leading infectious cause of blindness 49
Nov 15, 2017: Improving clinical trials with machine learning 51
Oct 31, 2017: GHIT Fund Accelerates Promising Efforts to Find New Treatments, Vaccines and Diagnostics for Malaria, Tuberculosis, Leishmaniasis and Mycetoma 52
Sep 15, 2017: Exciting discovery on path to develop new type of vaccine to treat global viruses 55
Aug 30, 2017: Tracing single brain cancer cells simplifies complexity of incurable brain cancers, suggesting new treatments, international study finds 57
Aug 07, 2017: CARB-X Funds Scientists Discovering New Antibiotics to Treat Deadly Superbugs 59
Jan 16, 2017: Cancer genetics refine treatment decisions 61
Other Significant Developments 63
Mar 28, 2018: As the GHIT Fund Closes Out First Five Years of R&D for Lifesaving Medical Breakthroughs, It Launches Next Phase, Focusing on Access and Delivery, Bringing Total Investment to 13.2 Billion Yen (US$123 Million) 63
Dec 07, 2017: New mental health research framework announced 66
Appendix 67
Methodology 67
About GlobalData 67
Contact Us 67
Disclaimer 67

List Of Tables

List of Tables
Wellcome Trust, Pharmaceuticals & Healthcare, Key Facts 2
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Wellcome Trust, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Wellcome Trust, Deals By Therapy Area, 2012 to YTD 2018 9
Wellcome Trust, Medical Devices Deals, 2012 to YTD 2018 10
Wellcome Trust, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Corinnova Raises USD6.1 Million from Wellcome Trust 14
Azellon Raises USD2 Million in Venture Financing 15
Kymab Raises USD100.5 Million in Series C Financing 17
Nabriva Therapeutics Raises USD120 Million in Series B Financing 19
Kymab Raises USD40 Million in Series B Financing 21
Pcovery Raises USD4 Million in Venture Financing 22
Biocartis Raises US$40.5 Million In Series E Financing 23
Pcovery Raises USD5.7 Million in Seed Financing 25
Trino Therapeutics Raises US$12 Million In Series A Financing 26
Canbex Therapeutics Raises US$3 Million In Venture Financing 28
Sigma-Aldrich Enters into Agreement with Sanger Institute 29
AstraZeneca Enters into Research Agreement with Wellcome Trust Sanger Institute 30
Merck Serono Enters into Co-Development Agreement with Institute of Cancer Research and Wellcome Trust 31
Katholieke Universiteit Leuven And Wellcome Trust Enter Into Agreement With Janssen Pharma To Develop Dengue Antiviral Drugs 32
Basilea Pharma Enters into Licensing Agreement for Novel PanRAF Kinase Inhibitors 34
Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute 35
Microbiotica Spin Off from Wellcome Trust Sanger Institute 36
Karuna Pharma Raises USD3.4 Million in Private Placement of Notes 37
Ergomed Acquires Haemostatix 38
GlaxoSmithKline Acquires Remaining Stake in GlycoVaxyn for USD190 Million 40
Wellcome Trust, Key Competitors 42
Wellcome Trust, Key Employees 43
Wellcome Trust, Subsidiaries 44

List Of Figures

List of Figures
Wellcome Trust, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Wellcome Trust, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Wellcome Trust, Medical Devices Deals, 2012 to YTD 2018 10

Wellcome Trust - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Wellcome Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Wellcome Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350 View Report

Wellcome Trust - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Wellcome Trust (Wellcome) is a charity that funds research organizations and research communities. It offers funding schemes to support individual researchers, teams and resources. The trust provides funds in areas

USD 250 View Report

Guys and St Thomas NHS Foundation Trust - Strategic SWOT Analysis Review

Guys and St Thomas NHS Foundation Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a

USD 125 View Report

Ramco-Gershenson Properties Trust - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Ramco-Gershenson Properties Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Ramco-Gershenson Properties Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available